These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28556500)

  • 1. Evaluation of sleep quality in patients with ankylosing spondylitis and efficacy of anti-TNF-α therapy on sleep problems: A polisomnographic study.
    Karatas G; Bal A; Yuceege M; Firat H; Gurcay E; Ardic S; Cakci FA
    Int J Rheum Dis; 2018 Jun; 21(6):1263-1269. PubMed ID: 28556500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of sleep quality and response to anti-tumor necrosis factor α therapy in rheumatoid arthritis patients.
    Karatas G; Bal A; Yuceege M; Yalcin E; Firat H; Dulgeroglu D; Karataş F; Sahin S; Cakci A; Ardic S
    Clin Rheumatol; 2017 Jan; 36(1):45-50. PubMed ID: 27567629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep Quality Is Related to Disease Activity in Patients With Ankylosing Spondylitis: A Polysomnographic Study.
    İn E; Turgut T; Gülkesen A; Yolbaş S; Akgöl G; Koca SS
    J Clin Rheumatol; 2016 Aug; 22(5):248-52. PubMed ID: 27464768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis.
    Karadağ O; Nakas D; Kalyoncu U; Akdoğan A; Kiraz S; Ertenli I
    Rheumatol Int; 2012 Jul; 32(7):1909-13. PubMed ID: 21448640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy.
    Prince DS; McGuigan LE; McGirr EE
    Int J Rheum Dis; 2014 Feb; 17(2):165-72. PubMed ID: 24576272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of global postural reeducation exercise and anti-TNF treatments on disease activity, function, fatigue, mobility, sleep quality and depression in patients with active Ankylosing spondylitis: A prospective follow-up study.
    Coksevim NH; Durmus D; Kuru O
    J Back Musculoskelet Rehabil; 2018; 31(6):1005-1012. PubMed ID: 30412478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis.
    Inci U; Yildiz A; Batmaz I; Tekbas E
    Int J Rheum Dis; 2017 Feb; 20(2):238-244. PubMed ID: 26012572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis of 234 Patients.
    Jacquemin C; Maksymowych WP; Boonen A; Gossec L
    J Rheumatol; 2017 Apr; 44(4):425-430. PubMed ID: 27980007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
    Pamuk ÖN; Kalyoncu U; Aksu K; Omma A; Pehlivan Y; Çağatay Y; Küçükşahin O; Dönmez S; Çetin GY; Mercan R; Bayındır Ö; Çefle A; Yıldız F; Balkarlı A; Kılıç L; Çakır N; Kısacık B; Öksüz MF; Çobankara V; Onat AM; Sayarlıoğlu M; Öztürk MA; Pamuk GE; Akkoç N
    Rheumatol Int; 2016 Jul; 36(7):945-53. PubMed ID: 27221456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of anti-TNF-alpha biologic drugs on the small bowel macroscopic inflammation in patients with ankylosing spondylitis.
    Chitul A; Voiosu AM; Marinescu M; Caraiola S; Nicolau A; Badea GC; Pârvu MI; Ionescu RA; Mateescu BR; Voiosu MR; Băicuş CR; Rimbaş M
    Rom J Intern Med; 2017 Mar; 55(1):44-52. PubMed ID: 28103201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practice.
    Arends S; van der Veer E; Kamps FB; Houtman PM; Bos R; Bootsma H; Brouwer E; Spoorenberg A
    Clin Exp Rheumatol; 2015; 33(2):174-80. PubMed ID: 25797228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
    Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
    J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study.
    Luchetti MM; Benfaremo D; Ciccia F; Bolognini L; Ciferri M; Farinelli A; Rossini M; Mosca P; Triolo G; Gabrielli A
    World J Gastroenterol; 2017 Oct; 23(39):7139-7149. PubMed ID: 29093622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restless legs syndrome is associated with poor sleep quality and quality of life in patients with ankylosing spondylitis: a questionnaire-based study.
    Demirci S; Demirci K; Doğru A; İnal EE; Koyuncuoğlu HR; Şahin M
    Acta Neurol Belg; 2016 Sep; 116(3):329-36. PubMed ID: 26563408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage adjustment of anti-tumor necrosis factor-α inhibitor in ankylosing spondylitis is effective in maintaining remission in clinical practice.
    Paccou J; Baclé-Boutry MA; Solau-Gervais E; Bele-Philippe P; Flipo RM
    J Rheumatol; 2012 Jul; 39(7):1418-23. PubMed ID: 22707611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sleep quality in patients with ankylosing spondylitis].
    Aydin E; Bayraktar K; Turan Y; Omurlu I; Tastaban E; Sendur OF
    Rev Bras Reumatol; 2015; 55(4):340-5. PubMed ID: 25772656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trial.
    Deodhar A; Braun J; Inman RD; Mack M; Parasuraman S; Buchanan J; Hsu B; Gathany T; van der Heijde D
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1266-71. PubMed ID: 20506403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
    de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
    Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the validity and reliability of the Jenkins Sleep Scale in ankylosing spondylitis.
    Duruoz MT; Ulutatar F; Ozturk EC; Unal-Ulutatar C; Sanal Toprak C; Kayhan O
    Int J Rheum Dis; 2019 Feb; 22(2):275-279. PubMed ID: 30565868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.